Machine learning has the potential to save thousands of people from skin cancer each year—while putting others at greater risk

Quick Read

With such enormous bodies, elephants should be particularly prone to tumors. But an ancient gene in their DNA, somehow resurrected, seems to shield the animals

Quick Read

History is repeating itself. Twenty years ago, a pain management crisis existed. As many as 70 percent of cancer patients in treatment at that time, or in end-of-life care, experienced unalleviated pain

Quick Read

Is it ethical to break cost-controlling rules for a patient’s benefit?

Quick Read

A gene-editing technology that is being explored by scientists worldwide as a way of removing and replacing gene defects might inadvertently increase cancer risk in cells, scientists warned on Monday

Quick Read

Drugs that activate the immune system to fight cancer have brought remarkable recoveries to many people in recent years. But one of those drugs seems to have had the opposite effect on three patients with an uncommon blood cancer who were taking part in a study

Quick Read

Q&A featuring comments from our Juli Murphy Bollinger

Quick Read

David Gerber writes, “I couldn’t think of a single way in which the patient’s prior experience with cancer would interfere with treatments or assessments on a lung cancer trial. And yet I couldn’t enroll him…. Unfortunately, many sick patients are being denied the opportunity to test new drugs that might save their lives. It’s time for this to change.”

Quick Read